ConocoPhillips Debt Securities fully and unconditionally guaranteed by ConocoPhillips Company and ConocoPhillips Australia Funding Company Debt Securities fully and unconditionally guaranteed by ConocoPhillips and ConocoPhillips Company UNDERWRITING...
EXHIBIT 1.1
EXECUTION VERSION
Debt Securities
fully and unconditionally guaranteed by ConocoPhillips Company
fully and unconditionally guaranteed by ConocoPhillips Company
and
ConocoPhillips Australia Funding Company
1. Introductory. ConocoPhillips, a Delaware corporation (“ConocoPhillips”), and
ConocoPhillips Company, a Delaware corporation and a wholly owned subsidiary of ConocoPhillips
(formerly named Xxxxxxxx Petroleum Company, hereinafter referred to as “CPCo”), propose that
ConocoPhillips will issue and sell from time to time certain of its unsecured debt securities fully
and unconditionally guaranteed by CPCo (the “ConocoPhillips Guarantor”) registered under the
registration statement referred to in Section 2(a) (such securities, including the guarantee
relating thereto by CPCo (the “ConocoPhillips Guarantee”), being hereinafter called the
“ConocoPhillips Registered Securities”). ConocoPhillips, CPCo and ConocoPhillips Australia Funding
Company, a Delaware corporation and a direct wholly owned special purpose finance subsidiary of
ConocoPhillips Australia Gas Holdings Pty Ltd (itself a wholly owned subsidiary of ConocoPhillips)
(“Funding”; Funding, together with ConocoPhillips jointly and severally, being hereafter called the
“Company”), further propose that Funding will issue and sell from time to time certain of its
unsecured debt securities fully and unconditionally guaranteed by ConocoPhillips and CPCo (the
“Funding Guarantors” and, together with the ConocoPhillips Guarantor, the “Guarantors”) registered
under the registration statement referred to in Section 2(a) (such securities, including the
guarantees relating thereto by ConocoPhillips and CPCo (the “Funding Guarantees” and, together with
the ConocoPhillips Guarantee, the “Guarantees”), being hereinafter called the “Funding Registered
Securities” and, together with the ConocoPhillips Registered Securities, the “Registered
Securities”). The ConocoPhillips Registered Securities will be issued under an indenture, dated as
of October 9, 2002 (the “ConocoPhillips Indenture”), among ConocoPhillips, CPCo and The Bank of New
York, as trustee (the “ConocoPhillips Trustee”), in one or more series, which series may vary as to
interest rates, maturities, redemption provisions, selling prices and other terms, with all such
terms for any particular series of the ConocoPhillips Registered Securities being determined at the
time of sale. The Funding Registered Securities will be issued under an indenture, to be dated as
of April 11, 2006 (the “Funding Indenture” and, together with the ConocoPhillips Indenture, the
“Indentures”), among ConocoPhillips, Funding and U.S. Bank National Association, as trustee (the
“Funding Trustee”), in one or more series, which series may vary as to interest rates, maturities,
redemption provisions,
2
selling prices and other terms, with all such terms for any particular series of the Funding
Registered Securities being determined at the time of sale. Particular series of the Registered
Securities will be sold pursuant to a Terms Agreement referred to in Section 3, for resale in
accordance with terms of offering determined at the time of sale.
The ConocoPhillips Registered Securities involved in any such offering are hereinafter
referred to as the “ConocoPhillips Offered Securities”. The Funding Registered Securities involved
in any such offering are hereinafter referred to as the “Funding Offered Securities” and, together
with the ConocoPhillips Offered Securities, the “Offered Securities”. The firm or firms which
agree to purchase the Offered Securities are hereinafter referred to as the “Underwriters” of such
securities, and the representative or representatives of the Underwriters, if any, specified in a
Terms Agreement referred to in Section 3 are hereinafter referred to as the “Representatives”;
provided, however, that if the Terms Agreement does not specify any representative of the
Underwriters, the term “Representatives”, as used in this Agreement (other than in Sections 2(b),
5(e) and 6 and the second sentence of Section 3), shall mean the Underwriters.
2. Representations and Warranties of the Company. The Company, as of the date of each Terms
Agreement referred to in Section 3, represents and warrants to, and agrees with, each Underwriter
that:
(a) The Company and CPCo meet the requirements for use of Form S-3 under the Act and
have prepared and filed with the Securities and Exchange Commission (“Commission”) an
automatic shelf registration statement, as defined in Rule 405, on Form S-3 (No. 333-13035,
000-000000-00 and 333-133035-02), including a prospectus (hereinafter referred to as the
“Base Prospectus”), relating to the Registered Securities, which registration statement
became effective upon filing. Such registration statement, as amended at the time of any
Terms Agreement referred to in Section 3 entered into in connection with a specific
offering of the Offered Securities (each such date and time as specified in such Terms
Agreement hereinafter referred to as the “Execution Time”) and including any documents
incorporated by reference therein, including exhibits (other than any Form T-1) and
financial statements and any prospectus supplement relating to the Offered Securities that
is filed with the Commission pursuant to Rule 424(b) (“Rule 424(b)”) under the Securities
Act of 1933 (the “Act”) and deemed part of such registration statement pursuant to Rule
430B under the Act, is hereinafter referred to as the “Registration Statement.” The Base
Prospectus, as supplemented as contemplated by Section 3 to reflect the terms of the
Offered Securities and the terms of offering thereof, as first filed with the Commission
pursuant to and in accordance with Rule 424(b), including all material incorporated by
reference therein, is hereinafter referred to as the “Final Prospectus.” Any preliminary
prospectus supplement to the Base Prospectus which describes the Offered Securities and the
offering thereof and is used prior to filing of the Final Prospectus, together with the
Base Prospectus, is hereinafter referred to as the “Preliminary Final Prospectus.” “Free
Writing Prospectus” shall mean a free writing prospectus, as defined in Rule 405 under the
Act.
3
”Issuer Free Writing Prospectus” shall mean an issuer free writing prospectus, as
defined in Rule 433 under the Act. “Disclosure Package” shall mean, with respect to any
specific offering of the Offered Securities, (i) the Base Prospectus, as amended and
supplemented to the Execution Time, (ii) the Preliminary Final Prospectus, if any, used
most recently prior to the Execution Time, (iii) the Issuer Free Writing Prospectuses, if
any, identified in Schedule B to the Terms Agreement, (iv) the final term sheet prepared
and filed pursuant to Section 4(c) hereto, if any, and (v) any other Free Writing
Prospectus that the parties hereto shall hereafter expressly agree in writing to treat as
part of the Disclosure Package. No document has been or will be prepared or distributed in
reliance on Rule 434 under the Act.
(b) On the effective date of the registration statement relating to the Registered
Securities, such registration statement conformed in all respects to the requirements of
the Act, the Trust Indenture Act of 1939 (“Trust Indenture Act”) and the rules and
regulations of the Commission (“Rules and Regulations”) and did not include any untrue
statement of a material fact or omit to state any material fact required to be stated
therein or necessary to make the statements therein not misleading, and at the Execution
Time and at the Closing Date, the Registration Statement and the Final Prospectus will
conform in all respects to the requirements of the Act, the Trust Indenture Act and the
Rules and Regulations, and neither of such documents will include any untrue statement of a
material fact or omit to state any material fact required to be stated therein or necessary
to make the statements therein not misleading, except that the foregoing does not apply to
statements in or omissions from any of such documents based upon written information
furnished to the Company by any Underwriter through the Representatives, if any,
specifically for use therein.
(c) At the Execution Time, the Disclosure Package will not contain any untrue
statement of a material fact or omit to state any material fact necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not
misleading, except that the foregoing does not apply to statements in or omissions from any
of such documents based upon written information furnished to the Company by any
Underwriter through the Representatives, if any, specifically for use therein.
(d) (i) At the time of filing the Registration Statement, (ii) at the time of the most
recent amendment thereto for the purposes of complying with Section 10(a)(3) of the Act
(whether such amendment was by post-effective amendment, incorporated report filed pursuant
to Sections 13 or 15(d) of the Exchange Act or form of prospectus), (iii) at the time the
Company or any person acting on its behalf (within the meaning, for this clause only, of
Rule 163(c)) made any offer relating to the Offered Securities in reliance on the exemption
in Rule 163, and (iv) at the Execution Time (with such date being used as the determination
date for purposes of this clause (iv)), the Company was or is (as the case may be) a
“well-known seasoned issuer” as defined in Rule 405. The Company agrees to pay the fees
required by the Commission relating to the Offered Securities within
4
the time required by Rule 456(b)(1) without regard to the proviso therein and
otherwise in accordance with Rules 456(b) and 457(r).
(e) (i) At the earliest time after the filing of the Registration Statement that the
Company or another offering participant made a bona fide offer (within the meaning of Rule
164(h)(2)) of any Offered Securities and (ii) as of the Execution Time (with such date
being used as the determination date for purposes of this clause (ii)), the Company was not
and is not an Ineligible Issuer (as defined in Rule 405), without taking account of any
determination by the Commission pursuant to Rule 405 that it is not necessary that the
Company be considered an Ineligible Issuer.
(f) Each Issuer Free Writing Prospectus, if any, and the final term sheet prepared and
filed pursuant to Section 4(c) hereto do not include any information that conflicts with
the information contained in the Registration Statement, including any document
incorporated by reference therein and any prospectus supplement deemed to be a part thereof
that has not been superseded or modified, except that the foregoing does not apply to
statements in or omissions from any of such documents based upon written information
furnished to the Company by any Underwriter through the Representatives, if any,
specifically for use therein.
3. Purchase and Offering of Offered Securities. The obligation of the Underwriters to
purchase the Offered Securities will be evidenced by an agreement or exchange of other written
communications (“Terms Agreement”) at the time the Company determines to sell the Offered
Securities. The Terms Agreement will incorporate by reference the provisions of this Agreement,
except as otherwise provided therein, and will specify the firm or firms which will be
Underwriters, the names of any Representatives, the principal amount of the Offered Securities to
be purchased by each Underwriter, the commission or fee to be paid to the Underwriters and the
terms of the Offered Securities not already specified in the Indentures, including, but not limited
to, interest rate, maturity, any redemption provisions and any sinking fund requirements. The
Terms Agreement will also specify the time and date of delivery and payment (such time and date, or
such other time not later than seven full business days thereafter as the Representatives and the
Company agree as the time for payment and delivery, being herein and in the Terms Agreement
referred to as the “Closing Date”), the place of delivery and payment and any details of the terms
of offering that should be reflected in the prospectus supplement relating to the offering of the
Offered Securities. For purposes of Rule 15c6-1 under the Securities Exchange Act of 1934, the
Closing Date (if later than the otherwise applicable settlement date) shall be the date for payment
of funds and delivery of securities for all the Offered Securities sold pursuant to the offering.
The obligations of the Underwriters to purchase the Offered Securities will be several and not
joint. It is understood that the Underwriters propose to offer the Offered Securities for sale as
set forth in the Prospectus.
If the Terms Agreement specifies “Book-Entry Only” settlement or otherwise states that the
provisions of this paragraph shall apply, each of ConocoPhillips and Funding will deliver against
payment of the cash purchase price the Offered Securities to
5
be issued by it in the form of one or more permanent global securities in definitive form (the
"Global Securities”) deposited with the Trustee as custodian for The Depository Trust Company
(“DTC”) and registered in the name of Cede & Co., as nominee for DTC. Interests in any permanent
global securities will be held only in book-entry form through DTC, except in the limited
circumstances described in the Final Prospectus. Payment for the ConocoPhillips Offered Securities
shall be made by the Underwriters in Federal (same day) funds by official check or checks or wire
transfer to an account previously designated by ConocoPhillips at a bank acceptable to the
Representatives, in each case drawn to the order of ConocoPhillips at the place of payment
specified in the Terms Agreement on the Closing Date, against delivery to the Trustee as custodian
for DTC of the Global Securities representing all of the ConocoPhillips Offered Securities. Payment
for the Funding Offered Securities shall be made by the Underwriters in Federal (same day) funds by
official check or checks or wire transfer to an account previously designated by Funding at a bank
acceptable to the Representatives, in each case drawn to the order of Funding at the place of
payment specified in the Terms Agreement on the Closing Date, against delivery to the Trustee as
custodian for DTC of the Global Securities representing all of the Funding Offered Securities.
4. Certain Agreements of the Company. The Company agrees with the several Underwriters that
it will furnish to counsel for the Underwriters one signed copy of the registration statement
relating to the Registered Securities, including all exhibits, in the form it became effective and
of all amendments thereto and that, in connection with each offering of Offered Securities:
(a) The Company will file the Final Prospectus with the Commission pursuant to and in
accordance with Rule 424(b)(2) (or, if applicable and if consented to by the
Representatives, subparagraph (5)) not later than the second business day following the
execution and delivery of the Terms Agreement.
(b) During any time when a prospectus relating to the Offered Securities is required
to be delivered under the Act in connection with sales by any Underwriter or dealer
(including in circumstances where such requirement may be satisfied pursuant to Rule 172),
the Company will advise the Representatives promptly of any proposal to amend or supplement
the Registration Statement or the Final Prospectus and will afford the Representatives a
reasonable opportunity to comment on any such proposed amendment or supplement; and the
Company will also advise the Representatives promptly of the filing of any such amendment
or supplement and of the institution by the Commission of any stop order proceedings or any
notice from the Commission objecting to its use in respect of the Registration Statement or
of any part thereof and will use its best efforts to prevent the issuance of any such stop
order and to obtain as soon as possible its lifting, if issued.
(c) The Company will prepare a final term sheet, containing solely a description of
the Offered Securities, in a form approved by the Representatives, and will file such term
sheet pursuant to Rule 433(d) under the Act within the time required by such Rule.
6
(d) If there occurs an event or development as a result of which the Disclosure
Package would include an untrue statement of a material fact or would omit to state a
material fact necessary in order to make the statements therein, in the light of the
circumstances then prevailing, not misleading, the Company will promptly notify the
Representatives, so that any use of the Disclosure Package may cease until it is amended or
supplemented, and will promptly prepare and file with the Commission, at its own expense,
an amendment or supplement that will correct such statement or omission or an amendment
that will effect such compliance.
(e) If, at any time when a prospectus relating to the Offered Securities is required
to be delivered under the Act in connection with sales by any Underwriter or dealer
(including in circumstances where such requirement may be satisfied pursuant to Rule 172),
any event occurs as a result of which the Final Prospectus as then amended or supplemented
would include an untrue statement of a material fact or omit to state any material fact
necessary to make the statements therein, in the light of the circumstances under which
they were made, not misleading, or if it is necessary at any time to amend the Final
Prospectus to comply with the Act, the Company promptly will notify the Representatives of
such event and will promptly prepare and file with the Commission, at its own expense, an
amendment or supplement that will correct such statement or omission or an amendment that
will effect such compliance. The terms “supplement” and “amendment” as used in this
Agreement include, without limitation, all documents filed by the Company with the
Commission subsequent to the date of the Final Prospectus that are deemed to be
incorporated by reference in the Final Prospectus. Neither the Representatives’ consent
to, nor the Underwriters’ delivery of, any such amendment or supplement shall constitute a
waiver of any of the conditions set forth in Section 5 hereof.
(f) As soon as practicable, but not later than 16 months, after the date of each Terms
Agreement, ConocoPhillips will make generally available to its security holders an earnings
statement covering a period of at least 12 months beginning after the latest of (i) the
effective date of the registration statement relating to the Registered Securities, (ii)
the effective date of the most recent post-effective amendment to the Registration
Statement to become effective prior to the date of such Terms Agreement and (iii) the date
of ConocoPhillips’ most recent Annual Report on Form 10-K filed with the Commission prior
to the date of such Terms Agreement, which will satisfy the provisions of Section 11(a) of
the Act.
(g) The Company will furnish to the Representatives copies of the Registration
Statement, including all exhibits, and during any time when a prospectus relating to the
Offered Securities is required to be delivered under the Act in connection with sales by
any Underwriter or dealer (including in circumstances where such requirement may be
satisfied pursuant to Rule 172), the Base Prospectus, any related Preliminary Final
Prospectus, the Final Prospectus and each Issuer Free Writing Prospectus and all amendments
and supplements to
7
such documents, in each case as soon as available and in such quantities as the
Representatives reasonably request.
(h) The Company will use its reasonable best efforts to arrange for the qualification
of the Offered Securities for sale and the determination of their eligibility for
investment under the laws of such jurisdictions as the Representatives designate and will
continue such qualifications in effect so long as required for the distribution; provided,
however, that none of ConocoPhillips, Funding or CPCo will be required in connection
therewith to register or qualify as a foreign corporation where it is not now so qualified
or to execute a general consent to service of process in any jurisdiction or subject itself
to taxation in any jurisdiction where it is not now so subject. The Company will promptly
advise the Representatives of the receipt by it or CPCo of any notification with respect to
the suspension of the qualification of the Offered Securities for offer and sale in any
such jurisdiction or the initiation or threatening of any proceeding for such purpose.
(i) During the period of five years after the date of any Terms Agreement, the Company
will furnish or make available to the Representatives and, upon request, to each of the
other Underwriters, if any, as soon as practicable after the end of each fiscal year, a
copy of ConocoPhillips’ annual report to stockholders for such year; and the Company will
furnish or make available to the Representatives (i) as soon as available, a copy of each
report (other than a report on Form 11-K) and any definitive proxy statement of
ConocoPhillips filed with the Commission under the Securities Exchange Act of 1934 or
mailed to stockholders, and (ii) from time to time, such other information concerning
ConocoPhillips, Funding or CPCo as the Representatives may reasonably request in connection
with the offering of the Offered Securities.
(j) The Company will pay all expenses incident to the performance of its obligations
under the Terms Agreement (including the provisions of this Agreement), for any filing fees
or other expenses (including reasonable fees and disbursements of counsel) in connection
with qualification of the Registered Securities for sale and determination of their
eligibility for investment under the laws of such jurisdictions as the Representatives may
designate in accordance with Section 4(h) and the printing of memoranda relating thereto,
for any fees charged by investment rating agencies for the rating of the Offered
Securities, for any applicable filing fee incident to, and the reasonable fees and
disbursements of counsel for the Underwriters in connection with, the review by the
National Association of Securities Dealers, Inc. of the Registered Securities, for any
travel expenses of the Company’s officers and employees and any other expenses of the
Company in connection with attending or hosting meetings with prospective purchasers of
Registered Securities and for expenses incurred in preparing, printing and distributing the
Prospectus, any preliminary prospectuses, any preliminary prospectus supplements or any
other amendments or supplements to the Prospectus to the Underwriters.
8
(k) The Company agrees that, unless it has obtained or will obtain, as the case may
be, the prior written consent of the Representatives, and each Underwriter, severally and
not jointly, agrees with the Company that, unless it has obtained or will obtain, as the
case may be, the prior written consent of the Company, it has not made and will not make
any offer relating to the Offered Securities that would constitute an Issuer Free Writing
Prospectus or that would otherwise constitute a “free writing prospectus” (as defined in
Rule 405) required to be filed by the Company with the Commission or retained by the
Company under Rule 433, other than the final term sheet prepared and filed pursuant to
Section 4(c) hereto; provided that the prior written consent of the parties hereto shall be
deemed to have been given in respect of the Free Writing Prospectuses, if any, included in
Schedule B to the applicable Terms Agreement. Any such free writing prospectus consented
to by the Representatives or the Company is hereinafter referred to as a “Permitted Free
Writing Prospectus.” The Company agrees that (x) it has treated and will treat, as the
case may be, each Permitted Free Writing Prospectus as an Issuer Free Writing Prospectus
and (y) it has complied and will comply, as the case may be, with the requirements of Rules
164 and 433 applicable to any Permitted Free Writing Prospectus, including in respect of
timely filing with the Commission, legending and record keeping.
(l) The Company consents to the use by any Underwriter of a free writing prospectus
that (a) is not an Issuer Free Writing Prospectus, and (b) contains only (i) information
describing the preliminary terms of the Offered Securities or their offering, (ii)
information required or permitted by Rule 134 under the Act that is not “issuer
information” as defined in Rule 433 or (iii) information that describes the final terms of
the Offered Securities or their offering and that is included in the final term sheet
prepared and filed pursuant to Section 4(c) hereto.
(m) Neither ConocoPhillips nor Funding will, and ConocoPhillips will cause CPCo not
to, offer, sell, contract to sell, pledge or otherwise dispose of, directly or indirectly,
or file with the Commission a registration statement under the Act relating to United
States dollar-denominated debt securities issued or guaranteed by ConocoPhillips, Funding
or CPCo and having a maturity of more than one year from the date of issue, or publicly
disclose the intention to make any such offer, sale, pledge, disposition or filing, without
the prior written consent of the Representatives for a period beginning at the time of
execution of the Terms Agreement and ending the number of days after the Closing Date
specified under “Blackout” in the Terms Agreement.
5. Conditions of the Obligations of the Underwriters. The obligations of the several
Underwriters to purchase and pay for the Offered Securities will be subject to the accuracy of the
representations and warranties on the part of the Company herein, to the accuracy of the statements
of Company officers made pursuant to the provisions hereof, to the performance by the Company of
its obligations hereunder and to the following additional conditions precedent:
9
(a) On or prior to the Execution Time, the Representatives, on behalf of the
Underwriters, shall have received a letter, dated the date of delivery thereof, of Ernst &
Young LLP confirming that they are independent registered public accountants within the
meaning of the Act and the applicable published Rules and Regulations thereunder and
stating to the effect that:
(i) in their opinion the financial statements and any schedules audited by
them and included or incorporated by reference in the Base Prospectus, Preliminary
Final Prospectus, Final Prospectus and the Disclosure Package comply as to form in
all material respects with the applicable accounting requirements of the Act and
the related published Rules and Regulations;
(ii) they have performed the procedures specified by the Public Company
Accounting Oversight Board for a review of interim financial information as
described in Statement of Auditing Standards No. 100, Interim Financial
Information, on any unaudited financial statements included in the Registration
Statement;
(iii) on the basis of the review referred to in clause (ii) above, a reading
of the latest available interim financial statements of ConocoPhillips, inquiries
of officials of ConocoPhillips who have responsibility for financial and accounting
matters and other specified procedures, nothing came to their attention that caused
them to believe that:
(A) the unaudited financial statements, if any, included in the
Disclosure Package or the Final Prospectus do not comply as to form in all
material respects with the applicable accounting requirements of the Act
and the related published Rules and Regulations or any material
modifications should be made to such unaudited financial statements for
them to be in conformity with generally accepted accounting principles;
(B) if any unaudited “capsule” information is contained in the
Disclosure Package or the Final Prospectus, the unaudited consolidated
total revenues, net income and net income per share amounts or other
amounts constituting such “capsule” information and described in such
letter do not agree with the corresponding amounts set forth in the
unaudited consolidated financial statements or were not determined on a
basis substantially consistent with that of the corresponding amounts in
the audited statements of income;
(C) at the date of the latest available balance sheet read by such
accountants, or at a subsequent specified date not more than three
business days prior to the date of the such letter, there was
10
any change in the capital stock or any increase in short-term
indebtedness or long-term debt of ConocoPhillips and its consolidated
subsidiaries or, at the date of the latest available balance sheet read by
such accountants, there was any decrease in consolidated net current
assets (working capital) or stockholders’ equity, as compared with amounts
shown on the latest balance sheet included in the Disclosure Package or
the Final Prospectus; or
(D) for the period from the closing date of the latest income
statement included in the Disclosure Package or the Final Prospectus to
the closing date of the latest available income statement read by such
accountants there were any decreases, as compared with the corresponding
period of the previous year and with the period of corresponding length
ended the date of the latest income statement included in the Disclosure
Package or the Final Prospectus, in consolidated total revenues or net
income;
except in all cases set forth in clauses (C) and (D) above for changes, increases
or decreases which the Disclosure Package and the Final Prospectus discloses have
occurred or may occur or which are described in such letter;
(iv) they have compared specified dollar amounts (or percentages derived from
such dollar amounts) and other financial information contained in the Registration
Statement, the Final Prospectus and the Disclosure Package (in each case to the
extent that such dollar amounts, percentages and other financial information are
derived from the general accounting records of ConocoPhillips and its subsidiaries
subject to the internal controls of ConocoPhillips’ accounting system or are
derived directly from such records by analysis or computation) with the results
obtained from inquiries, a reading of such general accounting records and other
procedures specified in such letter and have found such dollar amounts, percentages
and other financial information to be in agreement with such results, except as
otherwise specified in such letter; and
(v) they have read any pro forma financial information which is included in
the Disclosure Package or the Final Prospectus and performed the additional
procedures suggested by Example D of Statement of Auditing Standards No. 72.
All financial statements and schedules included in material incorporated by reference into
the Disclosure Package or the Final Prospectus shall be deemed included in the Disclosure
Package or the Final Prospectus for purposes of this subsection.
11
(b) The Final Prospectus shall have been filed with the Commission in accordance with
the Rules and Regulations and Section 4(a) of this Agreement. The final term sheet
contemplated by Section 4(c) hereto, and any other material required to be filed by
ConocoPhillips pursuant to Rule 433(d) under the Act, shall have been filed with the
Commission within the applicable time periods prescribed for such filings by Rule 433. No
stop order suspending the effectiveness of the Registration Statement or of any part
thereof or any notice from the Commission objecting to its use shall have been issued and
no proceedings for that purpose shall have been instituted or, to the knowledge of
ConocoPhillips, Funding or any Underwriter, shall be contemplated by the Commission.
(c) Subsequent to the execution of the Terms Agreement, there shall not have occurred
(i) any change, or any development or event involving a prospective change, in the
condition (financial or other), business, properties or results of operations of
ConocoPhillips and its subsidiaries taken as one enterprise which, in the judgment of a
majority in interest of the Underwriters including any Representatives, is material and
adverse and makes it impractical or inadvisable to proceed with completion of the public
offering or the sale of and payment for the Offered Securities; (ii) any downgrading in the
rating of any debt securities of ConocoPhillips by any “nationally recognized statistical
rating organization” (as defined for purposes of Rule 436(g) under the Act), or any public
announcement that any such organization has under surveillance or review its rating of any
debt securities of ConocoPhillips (other than an announcement with positive implications of
a possible upgrading, and no implication of a possible downgrading, of such rating); (iii)
any material suspension or material limitation of trading in securities generally on the
New York Stock Exchange, or any setting of minimum prices for trading on such exchange or
any suspension of trading of any securities of ConocoPhillips on any exchange or in the
over-the-counter market; (iv) any banking moratorium declared by U.S. Federal or New York
authorities; or (v) any outbreak or escalation of major hostilities in which the United
States is involved, any declaration of war by Congress or any other substantial national or
international calamity or emergency if, in the judgment of a majority in interest of the
Underwriters including any Representatives, the effect of any such outbreak, escalation,
declaration, calamity or emergency makes it impractical or inadvisable to proceed with
completion of the public offering or the sale of and payment for the Offered Securities.
(d) The Representatives, on behalf of the Underwriters, shall have received an
opinion, dated the Closing Date, of Xxxxx Xxxxx L.L.P., counsel for ConocoPhillips and
Funding, to the effect that:
(i) each of ConocoPhillips and Funding has been duly incorporated and is an
existing corporation in good standing under the laws of the State of Delaware, with
corporate power and authority to own its properties and conduct its business as
described in the Final Prospectus;
12
(ii) the ConocoPhillips Indenture has been duly authorized, executed and
delivered by ConocoPhillips and CPCo and has been duly qualified under the Trust
Indenture Act; the ConocoPhillips Offered Securities have been duly authorized,
executed, issued and delivered by ConocoPhillips; the ConocoPhillips Indenture and
the ConocoPhillips Offered Securities are valid and legally binding obligations of
ConocoPhillips, enforceable against ConocoPhillips in accordance with their terms,
the ConocoPhillips Indenture and the ConocoPhillips Guarantee of the ConocoPhillips
Guarantor have been duly authorized, executed and delivered by the ConocoPhillips
Guarantor and are valid and legally binding obligations of the ConocoPhillips
Guarantor, enforceable against the ConocoPhillips Guarantor in accordance with
their terms, except in each case to the extent such enforceability may be limited
by applicable bankruptcy, insolvency, fraudulent conveyance or transfer,
reorganization, moratorium and similar laws of general applicability relating to or
affecting creditors’ rights and to general principles of equity (whether considered
in a proceeding in equity or at law); and the ConocoPhillips Offered Securities
conform in all material respects to the description thereof contained in the
Disclosure Package and the Final Prospectus;
(iii) the Funding Indenture has been duly authorized, executed and delivered
by ConocoPhillips, Funding and CPCo and has been duly qualified under the Trust
Indenture Act; the Funding Offered Securities have been duly authorized, executed,
issued and delivered by Funding; the Funding Indenture and the Funding Offered
Securities are valid and legally binding obligations of Funding, enforceable
against Funding in accordance with their terms, and the Funding Indenture and the
Funding Guarantee of each Funding Guarantor have been duly authorized, executed and
delivered by each Funding Guarantor and are valid and legally binding obligations
of such Funding Guarantor, enforceable against such Funding Guarantor in accordance
with their terms, except in each case to the extent such enforceability may be
limited by applicable bankruptcy, insolvency, fraudulent conveyance or transfer,
reorganization, moratorium and similar laws of general applicability relating to or
affecting creditors’ rights and to general principles of equity (whether considered
in a proceeding in equity or at law); and the Funding Offered Securities conform in
all material respects to the description thereof contained in the Disclosure
Package and the Final Prospectus;
(iv) no consent, approval, authorization or order of, or filing with, any
governmental agency or body or any court is required under the Delaware General
Corporation Law, the laws of the State of Texas or the federal laws of the United
States for the consummation of the transactions contemplated by the Terms Agreement
(including the provisions of this Agreement) in connection with the issuance or
sale of the ConocoPhillips Offered Securities by ConocoPhillips or the Funding
Offered Securities by
13
Funding, except such as have been obtained and made under the Act and the
Trust Indenture Act and such as may be required under state securities laws;
(v) the execution, delivery and performance by ConocoPhillips of the
ConocoPhillips Indenture, the Funding Indenture and the Terms Agreement (including
the provisions of this Agreement) and by Funding of the Funding Indenture and the
Terms Agreement (including the provisions of this Agreement) and the issuance and
sale of the Offered Securities by ConocoPhillips and Funding, as applicable, and
compliance by ConocoPhillips and Funding, as applicable, with the terms and
provisions thereof will not result in a breach or violation of any of the terms and
provisions of, or constitute a default under, the Delaware General Corporation Law,
the laws of the State of Texas or the federal laws of the United States, and each
Guarantor has all necessary corporate power and authority to perform its Guarantee
as contemplated by the Indentures;
(vi) the Registration Statement has become effective under the Act, the Final
Prospectus was filed with the Commission pursuant to the subparagraph of Rule
424(b) specified in such opinion on the date specified therein, the final term
sheet contemplated by Section 4(c) hereto and any Issuer Free Writing Prospectus
specified in such opinion has been filed with the Commission within the applicable
time period prescribed therefor by Rule 433, and, to the knowledge of such counsel,
no stop order suspending the effectiveness of the Registration Statement or any
part thereof or any notice from the Commission objecting to its use has been issued
and no proceedings for that purpose have been instituted or are pending or
threatened under the Act, and the registration statement relating to the Registered
Securities, as of its effective date, the Registration Statement and the Final
Prospectus, as of the Execution Time, and any amendment or supplement thereto, as
of its date (in each case, other than the financial statements and schedules, the
notes thereto and the auditor’s reports thereon, management’s report on internal
control over financial reporting, if any, the other financial, reserve engineering,
numerical, statistical and accounting data included or incorporated by reference
therein, or omitted therefrom, as to which such counsel need not comment), appear
on their face to comply as to form in all material respects with the requirements
of the Act, the Trust Indenture Act and the Rules and Regulations; and
(vii) the Terms Agreement (including the provisions of this Agreement) has
been duly authorized, executed and delivered by ConocoPhillips and Funding.
14
(e) The Representatives, on behalf of the Underwriters, shall have received an
opinion, dated the Closing Date, of Xxxxx X. Xxxxx, Esq., senior counsel for
ConocoPhillips, to the effect that:
(i) ConocoPhillips is duly qualified to do business as a foreign corporation
in good standing in all jurisdictions in which its ownership or lease of property
or the conduct of its business requires such qualification, except to the extent
that the failure to be so qualified or be in good standing would not have a
material adverse effect on ConocoPhillips and its subsidiaries, taken as whole;
(ii) each Material Subsidiary of ConocoPhillips (as defined in the Terms
Agreement) has been duly incorporated, is validly existing as a corporation in good
standing under the laws of the jurisdiction of its incorporation, has the corporate
power and authority to own its property and to conduct its business as described in
the Final Prospectus and is duly qualified to transact business and is in good
standing in each jurisdiction in which the conduct of its business or its ownership
or leasing of property requires such qualification, except to the extent that the
failure to be so qualified or be in good standing would not have a material adverse
effect on ConocoPhillips and its subsidiaries, taken as a whole; all of the issued
shares of capital stock of each Material Subsidiary of ConocoPhillips have been
duly and validly authorized and issued, are fully paid and non-assessable; except
as set forth in the Final Prospectus, all of the issued shares of capital stock of
each Material Subsidiary and all partnership interests in any Material Subsidiary,
where applicable, are owned directly or indirectly by ConocoPhillips, free and
clear of all liens, encumbrances, equities or claims;
(iii) the execution, delivery and performance by ConocoPhillips of the
ConocoPhillips Indenture, the Funding Indenture and the Terms Agreement (including
the provisions of this Agreement) and by Funding of the Funding Indenture and the
Terms Agreement (including the provisions of this Agreement) and the issuance and
sale of the Offered Securities by ConocoPhillips and Funding, as applicable, and
compliance by ConocoPhillips and Funding, as applicable, with the terms and
provisions thereof will not result in a breach or violation of any of the terms and
provisions of, or constitute a default under, any agreement or instrument to which
ConocoPhillips, any Material Subsidiary or Funding is a party or by which
ConocoPhillips, any Material Subsidiary or Funding is bound or to which any of the
properties of ConocoPhillips, any Material Subsidiary or Funding is subject that is
material to ConocoPhillips and its subsidiaries, taken as a whole, or to Funding,
or the charter or by-laws of ConocoPhillips;
(iv) the descriptions in the Registration Statement and the Final Prospectus
of statutes, legal and governmental proceedings and contracts
15
and other documents are accurate in all material respects and fairly present
the information required to be shown; and
(v) such counsel does not know of any legal or governmental proceedings
pending or threatened to which ConocoPhillips or any of its subsidiaries is a party
or to which any of the properties of ConocoPhillips or any of its subsidiaries is
subject that, in such counsel’s judgment, are required to be described in the
Registration Statement or the Final Prospectus and are not so described or of any
statutes, regulations, contracts or other documents that are required to be
described in the Registration Statement or the Final Prospectus or to be filed as
exhibits to the Registration Statement that are not described or filed as required.
Such counsel shall also state that such counsel has participated in conferences with
officers and other representatives of ConocoPhillips, representatives of the independent
registered public accounting firm of ConocoPhillips, representatives of the Underwriters
and counsel to the Underwriters at which the contents of the Registration Statement, the
Final Prospectus and the Disclosure Package were discussed and, although such counsel did
not independently verify such information and is not passing upon and does not assume any
responsibility for the accuracy, completeness or fairness of the statements contained in
the Registration Statement, the Final Prospectus and the Disclosure Package, on the basis
of the foregoing no facts came to such counsel’s attention that led such counsel to believe
that the Registration Statement (other than the financial statements and schedules, the
notes thereto and the auditor’s reports thereon, management’s report on internal control
over financial reporting, if any, the other financial, reserve engineering, numerical,
statistical and accounting data included or incorporated by reference therein, or omitted
therefrom, and the exhibits thereto, as to which such counsel need not comment) as of its
effective date contained an untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary in order to make the statements
therein not misleading, or that the Final Prospectus (other than the financial statements
and schedules, the notes thereto and the auditors’ report thereon, management’s report on
internal control over financial reporting, if any, and the other financial, reserve
engineering, numerical, statistical and accounting data included or incorporated by
reference therein, or omitted therefrom, as to which such counsel need not comment) as of
its date or as of the Closing Date included an untrue statement of a material fact or
omitted to state a material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading, or that the
Disclosure Package (other than the financial statements and schedules, the notes thereto
and the auditors’ report thereon, management’s report on internal control over financial
reporting, if any, and the other financial, reserve engineering, numerical, statistical and
accounting data included or incorporated by reference therein, or omitted therefrom, as to
which such counsel need not comment) as of the Execution Time included an untrue statement
of a material fact or omitted to state
16
a material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading.
(f) The Representatives, on behalf of the Underwriters, shall have received from
Cravath, Swaine & Xxxxx LLP, counsel for the Underwriters, such opinion or opinions, dated
the Closing Date, with respect to the incorporation of ConocoPhillips, the validity of the
Offered Securities, the Registration Statement, the Final Prospectus, the Disclosure
Package and other related matters as the Representatives may require, and ConocoPhillips
shall have furnished to such counsel such documents as they request for the purpose of
enabling them to pass upon such matters.
(g) The Representatives, on behalf of the Underwriters, shall have received a
certificate, dated the Closing Date, of the President or any Vice President and a principal
financial or accounting officer of ConocoPhillips in which such officers, to the best of
their knowledge after reasonable investigation, shall state that the representations and
warranties of ConocoPhillips in this Agreement are true and correct, that ConocoPhillips
has complied with all agreements and satisfied all conditions on its part to be performed
or satisfied hereunder at or prior to the Closing Date, that no stop order suspending the
effectiveness of the Registration Statement or of any part thereof or any notice from the
Commission objecting to its use has been issued and no proceedings for that purpose have
been instituted or are contemplated by the Commission and that, subsequent to the date of
the most recent financial statements in the Prospectus, there has been no material adverse
change, nor any development or event involving a prospective material adverse change, in
the condition (financial or other), business, properties or results of operations of
ConocoPhillips and its subsidiaries taken as a whole except as set forth in or contemplated
by the Disclosure Package and the Final Prospectus or as described in such certificate.
(h) The Representatives, on behalf of the Underwriters, shall have received a
certificate, dated the Closing Date, of the President or any Vice President of Funding in
which such officer, to the best of his knowledge after reasonable investigation, shall
state that the representations and warranties of Funding in this Agreement are true and
correct, that Funding has complied with all agreements and satisfied all conditions on its
part to be performed or satisfied hereunder at or prior to the Closing Date and that no
stop order suspending the effectiveness of the Registration Statement or of any part
thereof has been issued and no proceedings for that purpose have been instituted or are
contemplated by the Commission, except as described in such certificate.
(i) The Representatives, on behalf of the Underwriters, shall have received a letter,
dated the Closing Date, of Xxxxx & Young LLP which meets the requirements of subsection (a)
of this Section, except that the specified date referred to in such subsection will be a
date not more than three days prior to the Closing Date for the purposes of this
subsection.
17
The Company will furnish the Representatives with such conformed copies of such opinions,
certificates, letters and documents as the Representatives reasonably request. The Representatives
may in their sole discretion waive on behalf of the Underwriters compliance with any conditions to
the obligations of the Underwriters under this Agreement and the Terms Agreement.
6. Indemnification and Contribution. (a) The Company will indemnify and hold harmless each
Underwriter, its partners, directors and officers and each person, if any, who controls such
Underwriter within the meaning of Section 15 of the Act, against any losses, claims, damages or
liabilities, joint or several, to which such Underwriter may become subject, under the Act or
otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof)
arise out of or are based upon any untrue statement or alleged untrue statement of any material
fact contained in the Registration Statement, the Base Prospectus, any Preliminary Final
Prospectus, the Final Prospectus, any Issuer Free Writing Prospectus or the information contained
in the final term sheet required to be prepared and filed pursuant to Section 4(c) hereto, or any
amendment or supplement thereto, or arise out of or are based upon the omission or alleged omission
to state therein a material fact required to be stated therein or necessary to make the statements
therein not misleading, and will reimburse each Underwriter for any legal or other expenses
reasonably incurred by such Underwriter in connection with investigating or defending any such
loss, claim, damage, liability or action as such expenses are incurred; provided, however, that
neither ConocoPhillips nor Funding will be liable in any such case to the extent that any such
loss, claim, damage or liability arises out of or is based upon an untrue statement or alleged
untrue statement in or omission or alleged omission from any of such documents in reliance upon and
in conformity with written information furnished to the Company by any Underwriter through the
Representatives, if any, specifically for use therein, it being understood and agreed that the only
such information furnished by any Underwriter consists of the information described as such in the
Terms Agreement.
(b) Each Underwriter will severally and not jointly indemnify and hold harmless
ConocoPhillips, Funding and CPCo, their respective directors and officers and each person,
if any, who controls ConocoPhillips, Funding and CPCo within the meaning of Section 15 of
the Act, against any losses, claims, damages or liabilities to which ConocoPhillips,
Funding or CPCo may become subject, under the Act or otherwise, insofar as such losses,
claims, damages or liabilities (or actions in respect thereof) arise out of or are based
upon any untrue statement or alleged untrue statement of any material fact contained in the
Registration Statement, the Base Prospectus, any Preliminary Final Prospectus, the Final
Prospectus, any Issuer Free Writing Prospectus or the information contained in the final
term sheet required to be prepared and filed pursuant to Section 4(c) hereto, or any
amendment or supplement thereto, or arise out of or are based upon the omission or the
alleged omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading, in each case to the extent, but
only to the extent, that such untrue statement or alleged untrue statement or omission or
alleged omission was made in reliance upon and in conformity with written information
furnished to the Company by such
18
Underwriter through the Representatives, if any, specifically for use therein, and
will reimburse any legal or other expenses reasonably incurred by ConocoPhillips, Funding
or CPCo in connection with investigating or defending any such loss, claim, damage,
liability or action as such expenses are incurred, it being understood and agreed that the
only such information furnished by any Underwriter consists of the information described as
such in the Terms Agreement.
(c) Promptly after receipt by an indemnified party under this Section of notice of the
commencement of any action, such indemnified party will, if a claim in respect thereof is
to be made against the indemnifying party under subsection (a) or (b) above, notify the
indemnifying party of the commencement thereof; but the omission so to notify the
indemnifying party will not relieve it from any liability which it may have to any
indemnified party otherwise than under subsection (a) or (b) above. In case any such
action is brought against any indemnified party and it notifies the indemnifying party of
the commencement thereof, the indemnifying party will be entitled to participate therein
and, to the extent that it may wish, jointly with any other indemnifying party similarly
notified, to assume the defense thereof, with counsel satisfactory to such indemnified
party (who shall not, except with the consent of the indemnified party, be counsel to the
indemnifying party), and after notice from the indemnifying party to such indemnified party
of its election so to assume the defense thereof, the indemnifying party will not be liable
to such indemnified party under this Section for any legal or other expenses subsequently
incurred by such indemnified party in connection with the defense thereof other than
reasonable costs of investigation. No indemnifying party shall, without the prior written
consent of the indemnified party, effect any settlement of any pending or threatened action
in respect of which any indemnified party is or could have been a party and indemnity could
have been sought hereunder by such indemnified party unless such settlement (i) includes an
unconditional release of such indemnified party from all liability on any claims that are
the subject matter of such action and (ii) does not include a statement as to, or an
admission of fault, culpability or a failure to act by or on behalf of an indemnified
party.
(d) If the indemnification provided for in this Section is unavailable or insufficient
to hold harmless an indemnified party under subsection (a) or (b) above, then each
indemnifying party shall contribute to the amount paid or payable by such indemnified party
as a result of the losses, claims, damages or liabilities referred to in subsection (a) or
(b) above (i) in such proportion as is appropriate to reflect the relative benefits
received by the Company on the one hand and the Underwriters on the other from the offering
of the Offered Securities or (ii) if the allocation provided by clause (i) above is not
permitted by applicable law, in such proportion as is appropriate to reflect not only the
relative benefits referred to in clause (i) above but also the relative fault of the
Company on the one hand and the Underwriters on the other in connection with the statements
or omissions which resulted in such losses, claims, damages or liabilities as well as any
other relevant equitable considerations. The relative benefits received by the
19
Company on the one hand and the Underwriters on the other shall be deemed to be in the
same proportion as the total net proceeds from the offering (before deducting expenses)
received by the Company bear to the total underwriting fees paid to (including any
underwriting discounts and commissions received by) the Underwriters. The relative fault
shall be determined by reference to, among other things, whether the untrue or alleged
untrue statement of a material fact or the omission or alleged omission to state a material
fact relates to information supplied by the Company or the Underwriters and the parties’
relative intent, knowledge, access to information and opportunity to correct or prevent
such untrue statement or omission. The amount paid by an indemnified party as a result of
the losses, claims, damages or liabilities referred to in the first sentence of this
subsection (d) shall be deemed to include any legal or other expenses reasonably incurred
by such indemnified party in connection with investigating or defending any action or claim
which is the subject of this subsection (d). Notwithstanding the provisions of this
subsection (d), no Underwriter shall be required to contribute any amount in excess of the
amount by which the total price at which the Offered Securities underwritten by it and
distributed to the public were offered to the public exceeds the amount of any damages
which such Underwriter has otherwise been required to pay by reason of such untrue or
alleged untrue statement or omission or alleged omission. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent misrepresentation. The
Underwriters’ obligations in this subsection (d) to contribute are several in proportion to
their respective underwriting obligations and not joint.
(e) The obligations of the Company under this Section shall be in addition to any
liability which the Company may otherwise have and shall extend, upon the same terms and
conditions, to the partners, directors, officers and each person, if any, who controls any
Underwriter within the meaning of the Act; and the obligations of the Underwriters under
this Section shall be in addition to any liability which the respective Underwriters may
otherwise have and shall extend, upon the same terms and conditions, to each director of
ConocoPhillips, Funding or CPCo, to each officer of ConocoPhillips, Funding or CPCo who has
signed the Registration Statement and to each person, if any, who controls ConocoPhillips,
Funding or CPCo within the meaning of the Act.
7. Default of Underwriters. If any Underwriter or Underwriters default in their obligations
to purchase Offered Securities under the Terms Agreement and the aggregate principal amount of
Offered Securities that such defaulting Underwriter or Underwriters agreed but failed to purchase
does not exceed 10% of the total principal amount of Offered Securities, the Representatives may
make arrangements satisfactory to the Company for the purchase of such Offered Securities by other
persons, including any of the Underwriters, but if no such arrangements are made by the Closing
Date, the non-defaulting Underwriters shall be obligated severally, in proportion to their
respective commitments under the Terms Agreement (including the provisions of this Agreement), to
purchase the Offered Securities that such defaulting Underwriters agreed but failed to
20
purchase. If any Underwriter or Underwriters so default and the aggregate principal amount of
Offered Securities with respect to which such default or defaults occur exceeds 10% of the total
principal amount of Offered Securities and arrangements satisfactory to the Representatives and the
Company for the purchase of such Offered Securities by other persons are not made within 36 hours
after such default, the Terms Agreement will terminate without liability on the part of any
non-defaulting Underwriter, ConocoPhillips, Funding or CPCo, except as provided in Section 8. As
used in this Agreement, the term “Underwriter” includes any person substituted for an Underwriter
under this Section. Nothing herein will relieve a defaulting Underwriter from liability for its
default.
8. Survival of Certain Representations and Obligations. The respective indemnities,
agreements, representations, warranties and other statements of ConocoPhillips, Funding or CPCo or
their respective officers and of the several Underwriters set forth in or made pursuant to the
Terms Agreement (including the provisions of this Agreement) will remain in full force and effect,
regardless of any investigation, or statement as to the results thereof, made by or on behalf of
any Underwriter, ConocoPhillips, Funding or CPCo or any of their respective representatives,
officers or directors or any controlling person, and will survive delivery of and payment for the
Offered Securities. If the Terms Agreement is terminated pursuant to Section 7 or if for any
reason the purchase of the Offered Securities by the Underwriters is not consummated, the Company
shall remain responsible for the expenses to be paid or reimbursed by it pursuant to Section 4 and
the respective obligations of the Company and the Underwriters pursuant to Section 6 shall remain
in effect. If the purchase of the Offered Securities by the Underwriters is not consummated for
any reason other than solely because of the termination of the Terms Agreement pursuant to Section
7 or the occurrence of any event specified in clause (iii), (iv) or (v) of Section 5(c), the
Company will reimburse the Underwriters for all out-of-pocket expenses (including fees and
disbursements of counsel) reasonably incurred by them in connection with the offering of the
Offered Securities.
9. No Fiduciary Duty. The Company hereby acknowledges that (a) the purchase and sale of any
Offered Securities pursuant to this Agreement and the applicable Terms Agreement is an arm’s-length
commercial transaction between the Company and CPCo, on the one hand, and the Underwriters and any
affiliate through which it may be acting, on the other, (b) the Underwriters are acting as
principal and not as an agent or fiduciary of the Company or CPCo and (c) the Company’s engagement
of the Underwriters in connection with any offering and the process leading up to the offering of
any Offered Securities is as independent contractors and not in any other capacity. Furthermore,
the Company agrees that it is solely responsible for making its own judgments in connection with
any offering (irrespective of whether any of the Underwriters has advised or is currently advising
the Company or CPCo on related or other matters). The Company agrees that it will not claim that
the Underwriters have rendered advisory services of any nature or respect, or owe an agency,
fiduciary or similar duty to the Company or CPCo, in connection with such offering or the process
leading thereto.
10. Notices. All communications hereunder will be in writing and, if sent to the
Underwriters, will be mailed, delivered or telegraphed and confirmed to them at their
21
address furnished to the Company in writing for the purpose of communications hereunder or, if
sent to the Company or CPCo, will be mailed, delivered or telegraphed and confirmed to it at
ConocoPhillips, 000 Xxxxx Xxxxx Xxxxxxx, Xxxxxxx, Xxxxx 00000, Attention: Chief Financial Officer.
11. Successors. The Terms Agreement (including the provisions of this Agreement) will inure
to the benefit of and be binding upon ConocoPhillips, Funding, CPCo and such Underwriters as are
identified in the Terms Agreement and their respective successors and the officers and directors
and controlling persons referred to in Section 6, and no other person will have any right or
obligation hereunder.
12. Representation of Underwriters. Any Representatives will act for the several Underwriters
in connection with the financing described in the Terms Agreement, and any action under such Terms
Agreement (including the provisions of this Agreement) taken by the Representatives will be binding
upon all the Underwriters.
13. Counterparts. The Terms Agreement may be executed in any number of counterparts, each of
which shall be deemed to be an original, but all such counterparts shall together constitute one
and the same Agreement.
14. Applicable Law. This Agreement and the Terms Agreement shall be governed by, and
construed in accordance with, the laws of the State of New York, without regard to principles of
conflicts of laws.
Each of ConocoPhillips, Funding and CPCo hereby submits to the non-exclusive jurisdiction of
the Federal and state courts in the Borough of Manhattan in The City of New York in any suit or
proceeding arising out of or relating to the Terms Agreement (including the provisions of this
Agreement) or the transactions contemplated thereby.
ConocoPhillips (“ConocoPhillips”)
Debt Securities
fully and unconditionally guaranteed by ConocoPhillips Company
fully and unconditionally guaranteed by ConocoPhillips Company
and
ConocoPhillips Australia Funding Company (“Funding” and, together with
ConocoPhillips, the “Company”)
ConocoPhillips, the “Company”)
Debt Securities
fully and unconditionally guaranteed by ConocoPhillips and ConocoPhillips Company
fully and unconditionally guaranteed by ConocoPhillips and ConocoPhillips Company
TERMS AGREEMENT
April 6, 2006
To: The Representatives of the Underwriters identified herein
Ladies & Gentlemen:
The Company agrees to sell to the several Underwriters named in Schedule A hereto for their
respective accounts, on and subject to the terms and conditions of the Underwriting Agreement to be
filed by ConocoPhillips in its Report on Form 8-K dated April 6, 2006 (“Underwriting Agreement”),
the following securities (“Offered Securities”) on the following terms:
Title: | Floating Rate Notes Due April 11, 2007 (“2007 Notes”). | |||
Floating Rate Notes Due April 9, 2009 (“2009 Notes”). | ||||
5.50% Notes Due 2013 (“2013 Notes”). | ||||
Principal Amount: | $1,000,000,000 of 2007 Notes. | |||
$1,250,000,000 of 2009 Notes. |
||||
$750,000,000 of 2013 Notes. |
Interest: Floating rate, subject to adjustment on a quarterly basis, based on the
three-month LIBOR rate plus 0% on the 2007 Notes from April 11, 2006, payable on January
11, April 11, July 11 and October 11 of each year, commencing July 11, 2006.
Floating rate, subject to adjustment on a quarterly basis based on the three-month
LIBOR rate plus 0.10% on the 2009 Notes from April 11, 2006, payable on January 9, April 9,
July 9 and October 9 of each year, commencing July 9, 2006.
2
5.50% per annum on the 2013 Notes from April 11, 2006, payable semiannually on April
15 and October 15, commencing October 15, 2006.
Maturity:
|
April 11, 2007 for the 2007 Notes. | |
April 9, 2009 for the 2009 Notes. |
||
April 15, 2013 for the 2013 Notes. |
Optional Redemption: ConocoPhillips may not redeem the 2007 notes prior to maturity.
Funding may redeem the 2009 Notes, in whole or in part, at any time and from time to time
on or after April 9, 2007 at a redemption price equal to 100% of the principal amount of
the 2009 Notes redeemed plus accrued but unpaid interest to the redemption date. Funding
may redeem the 2013 Notes, in whole or in part, at any time and from time to time,
according to the price formula set forth in the Final Prospectus.
Sinking Fund: None.
Listing: None.
Purchase Price: 100% of principal amount of the 2007 Notes; 100% of principal amount
of the 2009 Notes; and 99.81% of principal amount of the 2013 Notes plus, in each case,
accrued interest, if any, from April 11, 2006.
Underwriters’ Fee: 0.20% of principal amount of the 2007 Notes; 0.25% of principal
amount of the 2009 Notes; and 0.40% of principal amount of the 2013 Notes.
Cash Purchase Price: 100% of principal amount of the 2007 Notes less a fee equal to
0.20% of the principal amount; 100% of principal amount of the 2009 Notes less a fee equal
to 0.25% of the principal amount; 99.81% of principal amount of the 2013 Notes less a fee
equal to 0.40% of the principal amount plus, in each case, accrued interest, if any, from
April 11, 2006.
Expected Reoffering Price: 100% of principal amount of the 2007 Notes, 100% of
principal amount of the 2009 Notes, and 99.81% of principal amount of the 2013 Notes, in
each case subject to change by the Representatives.
Closing: 10:00 A.M. on April 11, 2006, at the offices of Cravath, Swaine & Xxxxx LLP,
000 Xxxxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000 in Federal (same day) funds.
Settlement and Trading: Book-Entry Only via DTC.
Blackout: Until 14 days after the Closing Date.
Names and Addresses of Representatives:
3
Citigroup Global Markets Inc.
000 Xxxxxxxxx Xxxxxx
Xxx Xxxx, XX 00000
000 Xxxxxxxxx Xxxxxx
Xxx Xxxx, XX 00000
Greenwich Capital Markets, Inc.
000 Xxxxxxxxx Xxxx
Xxxxxxxxx, XX 00000
000 Xxxxxxxxx Xxxx
Xxxxxxxxx, XX 00000
Banc of America Securities LLC
0 Xxxx 00xx Xxxxxx
Xxx Xxxx, XX 00000
0 Xxxx 00xx Xxxxxx
Xxx Xxxx, XX 00000
Barclays Capital Inc.
000 Xxxx Xxxxxx
Xxx Xxxx Xxxx, XX 00000
000 Xxxx Xxxxxx
Xxx Xxxx Xxxx, XX 00000
Execution Time: 5:00 p.m., New York city time, on the date hereof.
The respective principal amounts of the Offered Securities to be purchased by each of the
Underwriters are set forth opposite their names in Schedule A hereto.
The Underwriters will reimburse the Company $81,250 for certain of the Company’s expenses in
connection with the offering of the Offered Securities.
The Underwriters agree to offer the Funding Offered Securities to at least 10 institutional
investors, which, for purposes hereof, are entities carrying on a business of providing finance, or
investing or dealing in securities, in the course of operating in financial markets.
The provisions of the Underwriting Agreement are incorporated herein by reference. The
Material Subsidiaries of the Company are ConocoPhillips Company (formerly Xxxxxxxx Petroleum
Company) and Burlington Resources, Inc (“BR”).
For purposes of Section 6 of the Underwriting Agreement, the only information furnished to the
Company by any Underwriter for use in the Final Prospectus and the final term sheet prepared and
filed pursuant to Section 4(c) of the Underwriting Agreement consists of the following information
in the Prospectus furnished on behalf of each Underwriter: the fourth, fifth, sixth, eighth, ninth,
tenth and thirteenth paragraphs and the last sentence of the twelfth paragraph under the caption
“Underwriting” in the prospectus supplement.
Section 5 of the Underwriting Agreement is hereby amended by adding the following after
paragraph 5(i):
(j) On or prior to the Execution Time, the Representatives, on behalf of the Underwriters,
shall have received a letter, dated the date of delivery thereof, of
4
PricewaterhouseCoopers LLP confirming that they are independent registered public
accountants, with respect to BR, within the meaning of the Act and the applicable published
Rules and Regulations thereunder and stating to the effect that:
(i) in their opinion the financial statements and any schedules of BR audited
by them and incorporated by reference in the Base Prospectus, Preliminary Final
Prospectus, Final Prospectus and the Disclosure Package comply as to form in all
material respects with the applicable accounting requirements of the Act and the
related published Rules and Regulations;
(ii) they have compared specified dollar amounts (or percentages derived from
such dollar amounts) and other financial information contained in the Registration
Statement, the Final Prospectus and the Disclosure Package (in each case to the
extent that such dollar amounts, percentages and other financial information are
derived from the general accounting records of BR and its subsidiaries subject to
the internal controls of BR’s accounting system or are derived directly from such
records by analysis or computation) with the results obtained from a reading of
such general accounting records and other procedures specified in such letter and
have found such dollar amounts, percentages and other financial information to be
in agreement with such results, except as otherwise specified in such letter.
All financial statements and schedules of BR included in material incorporated by reference
into the Disclosure Package or the Final Prospectus shall be deemed included in the
Disclosure Package or the Final Prospectus for purposes of this subsection.
5
If the
foregoing is in accordance with your understanding of our agreement, kindly sign and
return to the Company one of the counterparts hereof, whereupon it will become a binding agreement
among ConocoPhillips, Funding and the several Underwriters in accordance with its terms.
Very truly yours,
ConocoPhillips |
||||
By | /s/ Xxxx X. Xxxxxx | |||
Name: | Xxxx X. Xxxxxx | |||
Title: | Vice President and Treasurer | |||
ConocoPhillips Australia Funding Company |
||||
By | /s/ Xxxx X. Xxxxxx | |||
Name: | Xxxx X. Xxxxxx | |||
Title: | Vice President and Treasurer |
6
The foregoing Terms Agreement is hereby confirmed
and accepted as of the date first above written.
and accepted as of the date first above written.
Citigroup Global Markets Inc.,
Greenwich Capital Markets, Inc.,
Banc of America Securities LLC,
Barclays Capital Inc.,
Greenwich Capital Markets, Inc.,
Banc of America Securities LLC,
Barclays Capital Inc.,
Acting on behalf of themselves and as
the Representatives of the several Underwriters.
the Representatives of the several Underwriters.
By Citigroup Global Markets Inc. |
||||
By | /s/ Xxxxx Xxxxxxxxx | |||
Name: | Xxxxx Xxxxxxxxx | |||
Title: | Director | |||
SCHEDULE A
Principal | Principal | Principal | ||||||||||
Amount of | Amount of | Amount of | ||||||||||
Underwriter | 2007 Notes | 2009 Notes | 2013 Notes | |||||||||
Citigroup Global Markets Inc. |
$ | 182,500,000 | $ | 228,125,000 | $ | 136,875,000 | ||||||
Greenwich Capital Markets, Inc. |
$ | 182,500,000 | $ | 228,125,000 | $ | 136,875,000 | ||||||
Banc of America Securities LLC |
$ | 182,500,000 | $ | 228,125,000 | $ | 136,875,000 | ||||||
Barclays Capital Inc. |
$ | 182,500,000 | $ | 228,125,000 | $ | 136,875,000 | ||||||
Lazard Capital Markets LLC |
$ | 140,000,000 | $ | 175,000,000 | $ | 105,000,000 | ||||||
BNP Paribas Securities Corp. |
$ | 10,000,000 | $ | 12,500,000 | $ | 7,500,000 | ||||||
Calyon Securities (USA) |
$ | 10,000,000 | $ | 12,500,000 | $ | 7,500,000 | ||||||
Credit Suisse Securities (USA) LLC |
$ | 10,000,000 | $ | 12,500,000 | $ | 7,500,000 | ||||||
Daiwa Securities America Inc. |
$ | 10,000,000 | $ | 12,500,000 | $ | 7,500,000 | ||||||
DnB NOR Markets, Inc. |
$ | 10,000,000 | $ | 12,500,000 | $ | 7,500,000 | ||||||
Deutsche Bank Securities Inc. |
$ | 10,000,000 | $ | 12,500,000 | $ | 7,500,000 | ||||||
HSBC Securities (USA) Inc. |
$ | 10,000,000 | $ | 12,500,000 | $ | 7,500,000 | ||||||
ING Financial Markets LLC |
$ | 10,000,000 | $ | 12,500,000 | $ | 7,500,000 | ||||||
LaSalle Financial Services, Inc. |
$ | 10,000,000 | $ | 12,500,000 | $ | 7,500,000 | ||||||
Xxxxxxx Xxxxx, Pierce, Fenner, &
Xxxxx Incorporated |
$ | 10,000,000 | $ | 12,500,000 | $ | 7,500,000 | ||||||
SG Americas Securities, LLC |
$ | 10,000,000 | $ | 12,500,000 | $ | 7,500,000 | ||||||
UBS Securities LLC |
$ | 10,000,000 | $ | 12,500,000 | $ | 7,500,000 | ||||||
Wachovia Capital Markets, LLC |
$ | 10,000,000 | $ | 12,500,000 | $ | 7,500,000 | ||||||
Total |
$ | 1,000,000,000 | $ | 1,250,000,000 | $ | 750,000,000 | ||||||
SCHEDULE B
Schedule of Free Writing Prospectuses included in the Disclosure Package
1. Free writing prospectus dated April 6, 2006, relating to the final terms of the Offered
Securities.